CD30 Regulation of IL-13–STAT6 Pathway in Breast Implant–Associated Anaplastic Large Cell Lymphoma |
Marshall E Kadin, MD, John Morgan, PhD, Wei Wei, PhD, Zhihui Song, PhD, Yibin Yang, PhD Aesthetic Surgery Journal, Volume 43, Issue 2, February 2023, Pages 137–146 Background: Breast implant–associated anaplastic large cell lymphoma (BIA-ALCL) is a rare, usually indolent CD30+ T-cell lymphoma with tumor cells, often surrounded by eosinophils, expressing IL-13 and pSTAT6. Objectives: The aim of this study was to understand the unique tumor pathology and growth regulation of BIA-ALCL, leading to potential targeted therapies. >> View on the Aesthetic Surgery Journal Website |
Bahman Guyuron, MD
“I give because plastic surgery is my passion and my business and the scientific studies supported through donations to ASERF work like Research and Development arm of any business; produce new and efficacious procedures and more importantly, assure patient safety” |
Copyright © 2009-2018 ASERF. 11262 Monarch St., Garden Grove, CA 92841-1441 P: 800-364-2147 F: 562-799-1098